PTEN and melanoma: We recently demonstrated that loss of PTEN impedes trafficking of effector T cells to tumors, reduces the sensitivity of melanoma cells to T cell mediated killing, and correlates with inferior outcomes in patients treated with immune checkpoint blockade.